- Home
- GRX vs KRRO Comparison
GRX vs KRRO Comparison
Compare GRX & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- KRRO
- Stock Information
- Founded
- GRX 2007
- KRRO 2014
- Country
- GRX United States
- KRRO United States
- Employees
- GRX N/A
- KRRO N/A
- Industry
- GRX Finance/Investors Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- KRRO Health Care
- Exchange
- GRX Nasdaq
- KRRO Nasdaq
- Market Cap
- GRX 145.5M
- KRRO 147.4M
- IPO Year
- GRX N/A
- KRRO 2019
- Fundamental
- Price
- GRX $9.16
- KRRO $33.22
- Analyst Decision
- GRX
- KRRO Strong Buy
- Analyst Count
- GRX 0
- KRRO 7
- Target Price
- GRX N/A
- KRRO $96.71
- AVG Volume (30 Days)
- GRX 39.7K
- KRRO 237.0K
- Earning Date
- GRX 01-01-0001
- KRRO 11-11-2025
- Dividend Yield
- GRX 5.98%
- KRRO N/A
- EPS Growth
- GRX N/A
- KRRO N/A
- EPS
- GRX 0.26
- KRRO N/A
- Revenue
- GRX N/A
- KRRO $6,281,000.00
- Revenue This Year
- GRX N/A
- KRRO $97.27
- Revenue Next Year
- GRX N/A
- KRRO N/A
- P/E Ratio
- GRX $38.50
- KRRO N/A
- Revenue Growth
- GRX N/A
- KRRO N/A
- 52 Week Low
- GRX $7.73
- KRRO $10.29
- 52 Week High
- GRX $10.40
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- GRX 33.40
- KRRO 67.72
- Support Level
- GRX $9.33
- KRRO $30.36
- Resistance Level
- GRX $9.22
- KRRO $37.03
- Average True Range (ATR)
- GRX 0.08
- KRRO 3.68
- MACD
- GRX -0.04
- KRRO -0.07
- Stochastic Oscillator
- GRX 2.27
- KRRO 77.36
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.